Navigation Links
Arthrex, Depuy Mitek, and Smith & Nephew Lead the $1.5 Billion U.S. Orthopedic Soft Tissue Market, Reports iData Research
Date:6/24/2013

Vancouver, BC (PRWEB) June 24, 2013

According to statistics released by the American Academy of Orthopaedic Surgeons along with the American Orthopaedic Society for Sports Medicine, there are approximately 150,000 ACL (anterior cruciate ligament) injuries each year in the United States. One of the main causes of ACL injury is direct impact to the knee, which often happens in high-contact sports such as football or basketball. However, most ACL tears happen when there is no contact between the knee and another object, and are instead a result of hyperextension or rapid change in direction, which happens often in agility sports. Since stitching the ligament together hardly ever proves to be successful, several techniques have been developed which involve reconstructing the ACL by building a ligament out of a graft substitute such as allografts, autografts, or xenografts. The high procedural costs of these surgeries account for a yearly healthcare expenditure of half a billion dollars.

According to the latest intelligence from iData Research, the leading authority in global market research, the market for orthopedic soft tissue repair is valued at over $1.5 billion, with the ACL/PCL reconstruction and fixation markets contributing to a significant portion of the total market. The two different types of reconstructions that can be done use either bone-patellar bone tendon-bone (BTB) grafts or soft tissue graft methods. “While BTB grafts are considered the gold standard in reconstruction procedures, soft tissue grafts produce less anterior knee pain, but are more prone to becoming stretched over time,” explains Dr. Kamran Zamanian, CEO of iData Research. For procedures using BTB grafts, only interference screws are used for anchoring the tendon or ligament of the graft to the bone. In contrast, for procedures that use soft tissue grafts, a variety of other devices are available to fixate the graft to the femoral and tibial tunnels.

The Muscoskeletal Transplant Foundation (MTF) led the ACL/PCL reconstruction market share in 2012. MTF is the largest tissue bank organization in the U.S. and is a non-profit service organization. RTI Biologics followed close behind, with a healthy level of growth that can be in part attributed to their release of 18 new implants and implant enhancements in 2012. In the fixation segment, Arthrex was the market leader, based on their high market share in nearly all material segments, particularly in the lucrative biocomposite segment. Depuy Mitek came in close second, with their Bio-INTRAFIX™ being considered as the gold standard fixation product for soft tissue tibial fixation. Moreover, Smith & Nephew was a major player, mostly due to their strength in the cortical fixation segment which they pioneered with the ENDOBUTTON® cortical fixation device. Other notable competitors in the reconstruction and fixation markets were AlloSource, LifeNet Health, ConMed Linvatec, Stryker, Biomet, Cayenne Medical, and ArthroCare.

A synopsis for each market intelligence publication in the global series on the Markets for Orthopedic Soft Tissue covering the U.S., China, India, Japan, Brazil, as well as 15 European countries is available here. The full series provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success strategies in each market and segment. The reports also cover markets for: cartilage repair, meniscal repair, rotator cuff repair, shoulder labrum repair, rotator cuff graft reinforcement devices, hip arthroscopy, and biceps tenodesis.

About iData Research

iData Research is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: arthroscopy, orthopedic biomaterials, orthopedic trauma, soft tissue repair, spinal implants and MIS, and orthopedic large and small joints.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10865382.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Now Urges All Recalled DePuy ASR Hip Implant Recipients Call Them For The Names Of The Best Attorneys Out Of Fear The Recipients Will Get Nothing
2. US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
3. US Drug Watchdog Now Offers To Help All Recipients Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Get To The Best Attorneys Regardless If Their Device Has Failed
4. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Know The Symptoms Of A Failure And Offers To Name The Best Lawyers & Law Firms For Failure Victims
5. US Drug Watchdog Now Offers To Help Every Recipient Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Who Had To Go Through Revision Surgery Get To The Best Lawyers
6. US Drug Watchdog Dramatically Increases Their Efforts To Get All Recalled DePuy ASR Hip Implant Recipients Identified To The Best Possible Attorneys Before Time Runs Out
7. US Drug Watchdog Now Offers To Help All Recalled DePuy ASR Hip Implant Recipients Get To The Best Attorneys Out Of Fear These Recipients Won't Be Compensated
8. The US Drug Watchdog Now Offers To Help All Recipients Of Recalled DePuy ASR Hip Implant Get To The Best Attorneys Because Time Could Run Out To Get Them Identified
9. US Drug Watchdog Says Its Critical All DePuy Pinnacle Hip Implant Recipients Know The Symptoms Of A Failure And They Offer The Names Of The Best Attorneys For Victims
10. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Get A Blood Test For Elevated Levels Of Cobalt Or Chromium and to Call Them If The Levels Are high
11. US Drug Watchdog Now Urges All DePuy Pinnacle And DePuy Hip Implant Recipients To Call Them For The Names Of The Best Law Firms Before Time Runs Out To Get Identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... , ... CDRH Enforcement Trends: , Back to the Future , Feb. 25, 2016 — 11:00 ... said, “Those who don’t learn from history are doomed to repeat it.” , An analysis ... this year. But that takes time. , Take a close look at the warning ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of coconut water beverages ... GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature ... event. The invitation-only gifting suite, held this year at the W Hollywood Hotel, has ...
(Date:2/12/2016)... ... ... Every winter, someone is killed, injured or loses a home in an accident ... of the Allegheny Health Network, has partnered with Etna Volunteer Fire Department, and Monroeville ... , “Space Heaters Need Space” aims to bring awareness to the risks ...
(Date:2/12/2016)... ... February 12, 2016 , ... Vail knee specialist ... Leaders to Know in 2016 . The list consists of physicians establishing, leading and ... establish this list. , An Ambulatory Surgery Center, also known as an ASC, ...
(Date:2/12/2016)... ... 12, 2016 , ... Miami Dental Specialists is excited to bring patients the ... Beginning in January, Miami Dental Specialists will offer the non-metal implants as a safe, ... to be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge technology ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
(Date:2/11/2016)... -- The primary goal of this research is to ... usage of liquid biopsy. Key information the survey seeks ... of liquid biopsy adoption amidst future users - Predominantly ... - Sample inflow to conduct liquid biopsy tests - ... so on. - Correlation analysis of sample type and ...
Breaking Medicine Technology: